Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 12 (RPL17P12)

Target: RPL17P12
Molecular classification: Other (Pseudogene), Ribosomal protein pseudogene

Overview

Ribosomal protein L17 pseudogene 12 (RPL17P12) is a processed pseudogene derived from the ribosomal protein L17 gene. Unlike its parent gene RPL17, which encodes a structural component of the large 60S ribosomal subunit, RPL17P12 does not encode a functional protein. Ribosomal protein pseudogenes like RPL17P12 are common in the human genome and are considered molecular fossils, typically non-coding and not involved in any known cellular or disease-related biological functions[2][3][4]. Pseudogenes can arise by retrotransposition or genomic duplication but are generally inactive due to mutations or truncations. RPL17P12 should not be considered a therapeutic target.

Other names: RPL17_6_281RPL17P12

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 12 (RPL17P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 12 (RPL17P12).

Explore the full profile